Tenaya Therapeutics, Inc. · NASDAQ:TNYA
The Column Group Opportunity III, LP reported a 32.00% stake in Tenaya Therapeutics, Inc. (Schedule 13D/A)
Event Mar 5, 2025 · Filed Mar 7, 2025
The Column Group Opportunity III, LP reported a 32.00% stake in Tenaya Therapeutics, Inc., 49,313,559 shares, with active intent on Mar 5, 2025. Filed Mar 7, 2025 (Schedule 13D/A).
- Stake
- 32.00%
- Shares
- 49,313,559
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Column Group III, LP | 2.90% | 4,414,720 |
| The Column Group III-A, LP | 3.20% | 4,985,570 |
| The Column Group III GP, LP | 6.10% | 9,400,290 |
| The Column Group Opportunity III, LP | 32.00% | 49,313,559 |
| The Column Group Opportunity III GP, LP | 32.00% | 49,313,559 |
| TCG Opportunity III GP, LLC | 32.00% | 49,313,559 |
Source
Related
- Tenaya Therapeutics, Inc.
- Column Group Opportunity III, LP
- Tenaya Therapeutics, Inc. shareholders
- Schedule 13D/A · Column Group Opportunity III, LP · Feb 26, 2026
- Schedule 13D/A · Column Group Opportunity III, LP · Dec 17, 2025
- Schedule 13D/A · Column Group Opportunity III, LP · May 14, 2025
- Form 4 · Ali Faraz · Sep 11, 2026
- Form 4 · Tingley Whittemore · Sep 11, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Form 4 · Ali Faraz · Aug 17, 2026
- Form 4 · Tingley Whittemore · Aug 17, 2026